This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2MM Bharath (2008) Therapeutic strategies in Parkinson's disease. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2, 135–147.
4A Goel , AB Kunnumakkara & BB Aggarwal (2008) Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol 75, 787–809.
5RB Mythri , B Jagatha , N Pradhan , (2007) Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid Redox Signal 9, 399–408.
6G Harish , C Venkateshappa , RB Mythri , (2010) Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: implications for Parkinson's disease. Bioorg Med Chem 18, 2631–2638.
7B Jagatha , RB Mythri , S Vali , (2008) Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic Biol Med 44, 907–917.
8C Ramassamy (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545, 51–64.
9HP Ammon & MA Wahl (1991) Pharmacology of Curcuma longa. Planta Med 57, 1–7.
10P Anand , AB Kunnumakkara , RA Newman , (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4, 807–818.
11RA Sharma , WP Steward & AJ Gescher (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595, 453–470.
12S Balaji & B Chempakam (2009) Pharmacokinetics prediction and drugability assessment of diphenylheptanoids from turmeric (Curcuma longa L.). Med Chem 5, 130–138.
13MA Ortiz-Ortiz , JM Moran , LM Ruiz-Mesa , (2010) Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Neurosci Lett 468, 120–124.
14MA Ortiz-Ortiz , JM Moran , JM Bravosanpedro , (2009) Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. Neurotoxicology 30, 1008–1018.
15RF Tayyem , DD Heath , WK Al-Delaimy , (2006) Curcumin content of turmeric and curry powders. Nutr Cancer 55, 126–131.
16XL Hou , K Takahashi , N Kinoshita , (2007) Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharm 337, 169–177.
17T Ahmed & AH Gilani (2009) Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol Biochem Behav 91, 554–559.
18GF Seelig & A Meister (1985) Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Methods Enzymol 113, 379–390.
20J Veena , BN Srikumar , K Mahati , (2009) Enriched environment restores hippocampal cell proliferation and ameliorates cognitive deficits in chronically stressed rats. J Neurosci Res 87, 831–843.
21J Veena , BN Srikumar , TR Raju , (2009) Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci Lett 455, 178–182.
22M Ebadi & SK Sharma (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid Redox Signal 5, 319–335.
23A Abeliovich & M Flint Beal (2006) Parkinsonism genes: culprits and clues. J Neurochem 99, 1062–1072.
24F Cicchetti , J Drouin-Ouellet & RE Gross (2009) Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30, 475–483.
25MP Mattson (2003) Gene–diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 139, 441–444.
26NE Bharucha , EP Bharucha , AE Bharucha , (1988) Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 45, 1321–1323.
27U Muthane , TC Yasha & SK Shankar (1998) Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 43, 283–287.
28PA Alladi , A Mahadevan , TC Yasha , (2009) Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease. Neuroscience 159, 236–245.
29M Ragothaman , UA Murgod , G Gururaj , (2003) Lower risk of Parkinson's disease in an admixed population of European and Indian origins. Mov Disord 18, 912–914.
31K Srinivasan (2005) Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr 56, 399–414.
33P Anand , C Sundaram , S Jhurani , (2008) Curcumin and cancer: an ‘old-age’ disease with an ‘age-old’ solution. Cancer Lett 267, 133–164.
34SJ Kim , TG Son , HR Park , (2008) Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 283, 14497–14505.
35Y Xu , B Ku , L Cui , (2007) Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 1162, 9–18.
36S Lalitha & R Selvam (1999) Prevention of H2O2-induced red blood cell lipid peroxidation and hemolysis by aqueous extracted turmeric. Asia Pac J Clin Nutr 8, 113–114.
38J Wang , XX Du , H Jiang , (2009) Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 78, 178–183.
39MF Beal (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 15, Suppl. 3, S189–S194.
40R Pal , EA Cristan , K Schnittker , (2010) Rescue of ER oxidoreductase function through polyphenolic phytochemical intervention: implications for subcellular traffic and neurodegenerative disorders. Biochem Biophys Res Commun 392, 567–571.
41S Yang , D Zhang , Z Yang , (2008) Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res 33, 2044–2053.
43H Sawada , M Ibi , T Kihara , (2002) Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model. Neuropharmacology 42, 1056–1064.
44S Yu , W Zheng , N Xin , (2010) Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res 13, 55–64.
45A Rajeswari & M Sabesan (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16, 96–99.
46J Chen , XQ Tang , JL Zhi , (2006) Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11, 943–953.
47V Zbarsky , KP Datla , S Parkar , (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 39, 1119–1125.
48N Pandey , J Strider , WC Nolan , (2008) Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol 115, 479–489.
49W Li , S Wang , J Feng , (2009) Structure elucidation and NMR assignments for curcuminoids from the rhizomes of Curcuma longa. Magn Reson Chem 47, 902–908.
50Y Zeng , F Qiu , K Takahashi , (2007) New sesquiterpenes and calebin derivatives from Curcuma longa. Chem Pharm Bull (Tokyo) 55, 940–943.
51DS Kim , SY Park & JK Kim (2001) Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1–42) insult. Neurosci Lett 303, 57–61.
52DS Kim & JY Kim (2001) Total synthesis of Calebin-A, preparation of its analogues, and their neuronal cell protectivity against beta-amyloid insult. Bioorg Med Chem Lett 11, 2541–2543.
53SY Park & DS Kim (2002) Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. J Nat Prod 65, 1227–1231.
54C Schiborr , GP Eckert , G Rimbach , (2010) A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem 397, 1917–1925.